4-Hydroxyphenylpyruvic acid | CAS:156-39-8
4-Hydroxyphenylpyruvic acid
- 名称:4-羟苯基丙酮酸; 对羟苯基丙酮酸 | 4-Hydroxyphenylpyruvic acid
- CAS号:156-39-8
- 别名:3-(4-Hydroxyphenyl)-2-oxopropanoic acid
- 分子式:C9H8O4
- 分子量:180.16
- EINESC号:205-852-9
产品描述
物理化学性质
熔点 | 219-220 ºC |
---|---|
水溶性 | 微溶 |
安全数据
危险品标志 | Xi |
---|---|
危险类别码 | R36/37/38 |
安全说明书 | S26;S37/39 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Hierarchy of interactions dictating the thermodynamics of real cell membranes: Following the insulin secretory granules paradigm up to fifteen-components vesicles.Francesca Saitta et al.Colloids and surfaces. B, Biointerfaces, 186, 110715-110715 (2019-12-17)
Oxidized Phospholipids Inhibit the Formation of Cholesterol-Dependent Plasma Membrane Nanoplatforms.Mario Brameshuber et al.Biophysical journal, 110(1), 205-213 (2016-01-09)
Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.Kimberly D Dyer et al.Journal of immunology (Baltimore, Md. : 1950), 184(11), 6327-6334 (2010-04-28)
Interfacial Structure and Hydration of 3D Lipid Monolayers in Aqueous Solution.Halil I Okur et al.The journal of physical chemistry. B, 121(13), 2808-2813 (2017-03-07)
Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells.Xinyuan Li et al.Redox biology, 28, 101373-101373 (2019-11-16)
The metabolic change in serum lysoglycerophospholipids intervened by triterpenoid saponins from Kuding tea on hyperlipidemic mice.Qingxin Shi et al.Food & function, 10(12), 7782-7792 (2019-11-30)
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.Mohamad Navab et al.Journal of lipid research, 56(4), 871-887 (2015-02-04)
Interfacial properties and critical micelle concentration of lysophospholipids.R E Stafford et al.Biochemistry, 28(12), 5113-5120 (1989-06-13)
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids.Nathan R Deleault et al.Proceedings of the National Academy of Sciences of the United States of America, 109(22), 8546-8551 (2012-05-16)
Lysophosphatidylcholine enhances NGF-induced MAPK and Akt signals through the extracellular domain of TrkA in PC12 cells.Wuhanqimuge et al.FEBS open bio, 3, 243-251 (2013-06-19)
Comprehensive and Reproducible Untargeted Lipidomic Workflow Using LC-QTOF Validated for Human Plasma Analysis.Anik Forest et al.Journal of proteome research, 17(11), 3657-3670 (2018-09-27)
In Situ Lipid Membrane Formation Triggered by Intramolecular Photoinduced Electron Transfer.Takafumi Enomoto et al.Langmuir : the ACS journal of surfaces and colloids, 34(3), 750-755 (2017-10-06)
OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators.Anthony J Valente et al.Free radical biology & medicine, 70, 117-128 (2014-02-25)
Porphyrin-phospholipid liposomes permeabilized by near-infrared light.Kevin A Carter et al.Nature communications, 5, 3546-3546 (2014-04-05)
Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A.Li V Yang et al.Blood, 105(3), 1127-1134 (2004-09-24)
Crystal structures of lysophospholipid-bound MHC class I molecules.Yoko Shima et al.The Journal of biological chemistry, 295(20), 6983-6991 (2020-04-10)
Anticancer Agent Edelfosine Exhibits a High Affinity for Cholesterol and Disorganizes Liquid-Ordered Membrane Structures.Alessio Ausili et al.Langmuir : the ACS journal of surfaces and colloids, 34(28), 8333-8346 (2018-06-21)
Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS).Dumindika A Siriwardane et al.International journal of pharmaceutics, 578, 119077-119077 (2020-01-29)
T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.Caius G Radu et al.Proceedings of the National Academy of Sciences of the United States of America, 101(1), 245-250 (2003-12-19)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!